April 2020 Newsletter

ALTERNATIVES to LIPOFECTION for NON-VIRAL DELIVERY of NUCLEIC ACIDS

RJH Biosciences is a biotechnology company whose focus is to realize the full potential of nucleic acids for human health. We developed a series of non-viral reagents that can be used to make nucleic acids functional in immunotherapy.


"All-Fect" Transfection Reagent for Modification of Immune (Jurkat) Cells with pDNA


Modified Immune (Jurkat) Cells to Eradicate CD19+ B-cells




TRANSFECTION REAGENTS NOW AVAILABLE AT NO COST FOR COVID-19 RESEARCH & DEVELOPMENT

For a limited time, RJH Biosciences Inc. is offering their transfection reagents and delivery systems to COVID-19 researchers worldwide at no cost (plus shipping). Please contact us directly for more information regarding this initiate.

"We hope that our reagents can be widely explored to better understand this disease and leave no stones unturned in the search for a cure"



For assistance in choosing the appropriate reagent, please refer to our selection guide




FEATURED PRODUCT

All-Fect: siRNA and pDNA Transfection Reagent

• Transient transfection with pDNA, siRNA, mRNA and co-delivery
• Attachment dependent and suspension-growing cells
• Stem cells, primary cells and cell lines




WE ARE HAPPY TO HELP!

Get personalized advice by an RJH representative on the best transfection methods for a specific application. We look forward to working with you soon.


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: